Company Filing History:
2 out of 6 
1 out of 6 Years Active: 2010-2012
Title: Haruyasu Yamaguchi: Innovator in Monoclonal Antibody Research
Introduction
Haruyasu Yamaguchi is a notable inventor located in Maebashi, Japan. He holds a total of three patents, focusing primarily on advancements in monoclonal antibodies and their therapeutic applications, particularly for Alzheimer's disease. His innovative work demonstrates a profound impact on medical science and research.
Latest Patents
Yamaguchi's latest patents include innovative discoveries in monoclonal antibodies that can specifically recognize amyloid beta while not recognizing amyloid beta precursor proteins. His methodologies involve creating antibodies capable of recognizing the N-terminus peptide of amyloid beta, leading to the development of an amyloid beta assay kit and a therapeutic agent to treat Alzheimer's disease. These patents are significant as they present novel approaches in the fight against Alzheimer's, highlighting his contributions to the field.
Career Highlights
Throughout his career, Haruyasu Yamaguchi has made significant strides in the medical research sector. Notable companies he has worked with include Intellect Neurosciences Inc. and Immuno-biological Laboratories Co., Ltd. His contributions at these organizations have further established his reputation as a leading inventor in the field of neurodegenerative diseases.
Collaborations
Yamaguchi's work was enhanced through collaborations with esteemed colleagues such as Noriaki Kinoshita and Masahiro Maeda. These partnerships have likely contributed to the refinement and success of his research and innovations.
Conclusion
In summary, Haruyasu Yamaguchi has made remarkable contributions to the field of medical science through his patented inventions. His focus on monoclonal antibodies and their applications in Alzheimer's treatment marks him as a significant figure in innovation, and his work continues to influence research and development in this critical area of healthcare.